Logo

Lincoln Pharmaceuticals Ltd. Share Price

Lincoln Pharmaceuticals Ltd. (INR)798-2.9   (-0.4%)

Exchange ScripsBSE531633NSELINCOLNISININE405C01035

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Lincoln Pharmaceuticals Ltd. Performance

Market performance
Open price812.65
High815.7
Volumes28805
Prev Close798
Low793.05
Closing date2025-01-20
Historical performance
1 Year High979.50
3 Year High979.50
5 Year High979.50
1 Year Low534.80
3 Year Low255.00
5 Year Low85.05

Lincoln Pharmaceuticals Ltd. Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
1566
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
17.13
Dividend Yield
Dividend Yield
0.02 %

Lincoln Pharmaceuticals Ltd. Investment Returns

1 Year
20.3%
3 Years
117.1%
5 Years
291.2%
10 Years
N/A

Lincoln Pharmaceuticals Ltd. Technicals

IndicatorsValueSignal
5-DMA792.07Bullish
10-DMA799.66Bearish
20-DMA805.06Bearish
50-DMA776.02Bullish
100-DMA737.67Bullish
200-DMA678.51Bullish

Shareholding Pattern

FieldDec-2024Sep-2024Jun-2024Mar-2024Dec-2023
Promoters2525252525
Foreign Investors---------------
Domestic Investors2525252525
Public Investors3182331305299423135029291
Government---------------

Lincoln Pharmaceuticals Ltd. Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income34422510057
Operating Profit134311171055928
Interest15201516
Depreciation106928176
Profit Before Tax12221005959837
Consolidated Net Profit933729694623
Adjusted EPS47363531

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital200200200200
Total Reserves5728482441283464
Minority Interest------------
Total Non-Current Liabilities152380110261
Total Liabilities7254636555464873
Capital Work in Progress356716117
Total Assets7254636555464873

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities632393761693
Cash Flow from Investing Activities-573-366-781-642
Cash Flow from Financing Activitie-52-45-26-57
Net Cash Inflow / Outflow7-19-45-7
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 17.13.
  • 3Y Stock Price CAGR of the stock is 30.2.
  • The stock has a beta of 1.0.
  • In the last financial year, the company had an EBITDA of ₹1343 Million.
  • The company generated revenue of ₹5805 Million in the previous financial year.

Lincoln Pharmaceuticals Ltd.

798-2.9   (-0.4%)

Investment Amount: ₹ 66200
Current Value: ₹ 79800
Performance: 20.5%
P/L: ₹ 13600
Top Gainers
SymbolChange%
SHIVATEX232.68(20%)
TTML82.73(17%)
GLOBUSSPR926.3(16%)
APOLLO151.28(15%)
KRITINUT132.26(13%)
Top Losers
SymbolChange%
PGIL1383.1(-18%)
SHARDACROP656.85(-10%)
QUADFUTURE540(-10%)
MAMATA479.25(-8%)
SGLTL177.18(-7%)
RALLIS269.95(-7%)
SWANENERGY639.3(-7%)
BLS469.55(-6%)
Similar stocks

Medico Remedies Ltd.

35

67.46

December 20 - January 20

Zota Health Care Ltd.

25.8

985.7

December 20 - January 20

Bajaj Healthcare Ltd.

21.5

648.5

December 20 - January 20

Biocon Ltd.

19.5

401.55

December 20 - January 20

Aarti Pharmalabs Ltd.

19

679.6

December 20 - January 20

Indegene Ltd.

14.6

673.75

December 20 - January 20

Alpa Laboratories Ltd.

11.2

129.12

December 20 - January 20

Akums Drugs & Pharmaceuticals Ltd.

9.4

626.5

December 20 - January 20

Announcing Stock of the Month!

Stock of the Month
Stock of the Month